What is Studio Optix?
Operating out of the iconic Rockefeller Center, Studio Optix functions as a dual-purpose enterprise, blending a high-volume optometric practice with a luxury optical boutique. The company distinguishes itself through a massive inventory of over 5,000 frames sourced from more than 100 global manufacturers, alongside a specialized focus on medical contact lens fittings. By integrating routine clinical eye care with a premium retail experience, the firm has established a unique market position that caters to both the medical needs and aesthetic preferences of a diverse, high-net-worth clientele in Manhattan. Its reputation as a leading contact lens provider further reinforces its operational authority in the regional healthcare landscape.
How much funding has Studio Optix raised?
Studio Optix has raised a total of $389K across 2 funding rounds:
Debt
$150K
Debt
$239K
Debt (2020): $150K with participation from PPP
Debt (2021): $239K led by PPP
Key Investors in Studio Optix
PPP
Public-Private Partnership
What's next for Studio Optix?
With the successful acquisition of this late-stage capital, Studio Optix is well-positioned to optimize its supply chain and expand its clinical service offerings. The strategic focus will likely shift toward enhancing patient throughput and scaling its digital infrastructure to support the growing demand for specialized contact lens solutions. As the company continues to navigate the complexities of the New York City retail market, this influx of financing provides the necessary liquidity to sustain its growth trajectory and maintain its status as a top-tier destination for comprehensive eye care and high-fashion eyewear.
See full Studio Optix company page
